trial seenhigh2026-10-19
null → {"status":"ACTIVE_NOT_RECRUITING","last_update_posted_at":"2026-10-19"}
📡 TrialPulse
Global clinical trial visibility
ACTIVE NOT RECRUITINGPHASE2
A Study With CIT-013 in HS Patients
Registry history
Events detected for this trial — severity × confidence × recency
How to read the confidence score: 1.0 = observed — the registry record itself changed (a fact). <1.0 (e.g. 0.7) = signal — inferred by a heuristic rule from the data; it flags something worth a look, it is not a confirmed finding. Values below are shown raw from the database; the highlighted parts are the actual values, dimmed parts are JSON syntax.
Key dates
Start2025-10-31
Primary completion2027-04
Enrollment108actual
Hidradenitis Suppurativa (HS)DRUG
Site map
Per-site markers colored by site status
unknownCA-01Barrie, Canada
unknownCA-05Calgary, Canada
unknownCA-02London, Canada
unknownCA-04Newmarket, Canada
unknownCA-03Winnipeg, Canada
unknownDE-06Bad Bentheim, Germany
unknownDE-01Bochum, Germany
unknownDE-04Dresden, Germany
unknownDE-02Frankfurt, Germany
unknownDE-08Kiel, Germany
unknownDE-03Oldenburg, Germany
unknownErasmus UMCRotterdam, Netherlands
unknownPL-06Bialystok, Poland
unknownPL-08Gdansk, Poland
unknownPL-03Katowice, Poland
unknownPL-02Lodz, Poland
unknownPL-10Lodz, Poland
unknownPL-09Poznan, Poland
unknownPL-01Rzeszów, Poland
unknownPL-05Wroclaw, Poland
unknownES-05Barcelona, Spain
unknownES-04Madrid, Spain
unknownES-02Santiago de Compostela, Spain
unknownES-03Seville, Spain
unknownES-01Valencia, Spain
unknownGB-02Cardiff, United Kingdom
unknownGB-05Chester, United Kingdom
unknownGB-04London, United Kingdom